Nucletron Central Europe Users Meeting
|
|
|
- Myles Lang
- 10 years ago
- Views:
Transcription
1 With delight we present you the preliminary agenda for the Nucletron Central Europe Users Meeting, which will be held on October 2009 in Budapest, Hungary. We have aimed for an inspiring programme that looks at brachytherapy from both a scientific and a practical perspective. A Toolkit for Good Medical Practice in Brachytherapy is therefore the theme for this meeting. A host of nationally and internationally renowned experts will address all significant aspects in a series of interactive talks, discussions and video demonstrations. In addition to sharing experiences and giving feedback on new Nucletron technology, we want to focus on how to successfully implement clinical protocols and procedures that drive good-quality results within the technological and socioeconomic context of Central Europe. Brachytherapy has always been the mainstay for treating gynaecological cancers and in fact the standard of care in Central Europe. Going forward, brachytherapy will play an even more crucial role, not only because of the rising incidence of indications like prostate and breast cancer but primarily because of its proven efficacy and efficiency in treating these diseases. At the same time, clinical and technological developments are driving the transition from 2-D (implant-based) to 3-D (volumebased) treatment planning and reinforcing the use of image-guidance for (interstitial) applications. These important developments offer vital inspiration for exploring and discussing sensible solutions that are relevant for your practice. That is why this year s Central Europe Users Meeting will focus on the opportunity to expand from GYN to other body sites and the benefit from key advancements in image-guided and adaptive brachytherapy by using knowledge and technology that is currently available to you. This meeting intends to offer you a toolkit for expanding the extraordinary potential of brachytherapy by breaking the barriers through clinical proof, cost-effectiveness and education. Scientific Committee MD PhD (Budapest) PhD (Budapest) Members MD PhD (Budapest) Jenő Bolgár MD (Kecskemét, HU) Janaki Hadijev MD PhD (Kaposvár, HU) János Fodor MD PhD DSc (Budapest) Erika Groska MSc (Gyula, HU) László Mangel MD PhD (Pécs, HU) József Lövey MD PhD (Budapest) Jenő Pálvölgyi PhD (Győr, HU) Béla Pikó MD (Gyula, HU) Kofi Agyemang Prempeh MD (Győr, HU) Kornélia Szluha MD PhD (Debrecen, HU) László Takácsi-Nagy MD PhD (Budapest) Zoltán Takácsi-Nagy MD PhD (Budapest) Prof László Thurzó MD PhD (Szeged, HU) International Invited Speakers Prof Dimos Baltas PhD DSc (Offenbach, DE) Catharina Beskow MD PhD (Stockholm, SE) Brygida Białas MD PhD (Gliwice, PL) MD (Royal Oak, MI USA) MD (Örebro, SE) Prof Christian Kirisits PhD DSc (Vienna, AT) Gabor Kacso MD (Cluj-Napoca, RO) Anna Kulik MD PhD (Warsaw, PL) Jarosław Łyczek MD PhD (Warsaw, PL) Prof Bogusław Maciejewski MD PhD DSc (Gliwice, PL) Prof Julian Malicki PhD DSc (Poznań, PL) Maryla Kawczyńska PhD (Warsaw, PL) Primož Petrič MD (Ljubljana, SLO) Prof Pavel Slampa MD PhD (Brno, CZ) Prof Andrzej Roszak MD PhD DSc (Poznań, PL) Prof Janusz Skowronek MD PhD DSc (Poznań, PL) Prof Renata Soumarová MD PhD (Novy Jicín, CZ) Grzegorz Zwierzchowski MD PhD (Poznań, PL) Nucletron Speakers Marjorie Imhoff PhD Eric Sewsingh BSc Lisette van der Vight BSc Mehmet Üzümcü PhD Organisers National Institute of Oncology Budapest MD PhD PhD MD Nucletron Netherlands Antar El-Mecky MA Jeske van der Sluijs Hans Galesloot MBA 1
2 Thursday, 15 October :00 14:30 Registration 13:30 14:30 Lunch OPENING CEREMONY 14:30 14:45 Welcome Speeches Jos Lamers CEO Nucletron Head of Radiotherapy NIO, Budapest 14:45 15:00 Speeches by Honorary Patrons Prof Dr Miklós Kásler Director NIO, Budapest László Mangel, President of the Hungarian Society for Radiation Oncology ORAL SESSION I BREAST BRACHYTHERAPY MULTICATHETER APBI Chairpersons Anna Kulik and János Fodor 15:00 15:20 Current Status and Future Perspectives of Multicatheter Breast Brachytherapy 15:20 15:35 15:35 15:50 15:50 16:00 Discussion LDR and HDR Multicatheter APBI 12-Year Result of William Beaumont Hospitals, Royal Oak, MI, USA HDR Multicatheter Brachytherapy for APBI Technique and Long-Term Results of Örebro University Hospital 16:00 16:30 Coffee Break VIDEO PRESENTATION I 16:30 16:50 Breast Implantation Using Nucletron Comfort Catheters and Oncentra Brachy Treatment Planning System 16:50 17:10 New Technology for Breast Brachytherapy 17:10 17:30 Discussion ROUND-TABLE DISCUSSION I 17:30 18:15 BREAST BRACHYTHERAPY Jarosław Łyczek Should We Keep our Good Old Breast Implant Techniques and 2-D Planning or Should We Go for CT-Based Conformal Brachytherapy Planning? Anna Kulik János Fodor Marjorie Imhoff Eric Sewsingh Anna Kulik János Fodor Christian Kirisits Pavel Slampa ORAL SESSION II PROFERRED PAPERS ON BREAST BRACHYTHERAPY Bengt Johansson and Pavel Slampa 3-D CT-Based HDR Interstitial BT for Localised Breast Cancer Plan Evaluation: M.S. Patel Cancer Centre Ganesan Senthil 18:15 18:40 Experience IPSA vs. Geometry-Based Optimisation in Dose Distribution Calculation in Accelerated Partial Breast Irradiation Marta Szlag 19:00 23:00 Dinner and Evening Programme 2
3 Friday, 16 October 2009 ORAL SESSION III IS THERE ARE A ROLE FOR PREOPERATIVE BRACHYTHERAPY IN TREATING GYN TUMOURS? Chairpersons Catharina Beskow and László Thurzó 08:30 08:45 Pathologic Complete Remission after Preoperative Intracavitary Radiotherapy of Cervical Cancer: Catharina Beskow The Radiumhemmet Experience 08:45 09:00 Tolerance and Efficacy of Preoperative Intracavitary HDR Brachytherapy in IB and IIA Cervical Cancer Brygida Białas 09:00 09:15 Preoperative HDR Brachytherapy in the Treatment of Operable Cervical Carcinoma Status of the Hungarian Júlia Vízkeleti Multicentric Randomised Clinical Trial 09:15 09:45 New Technology for Image-guided Adaptive Brachytherapy for Gynaecological Tumours Lisette van der Vight 09:45 10:00 Discussion Catharina Beskow László Thurzó 10:00 10:30 Coffee Break ROUND-TABLE DISCUSSION II GYNAECOLOGICAL BRACHYTHERAPY Primož Petrič Brygida Białas Christian Kirisits 10:30 11:15 Performing Successful Intracavitary Gynaecological Jarosław Łyczek Brachytherapy without Access to an MRI Facility Andrej Roszak László Thurzó ORAL SESSION IV PROFFERED PAPERS GYNAECOLOGICAL BRACHYTHERAPY László Mangel and Andrzej Roszak Analysis of Standard Loading Patterns for Cervix BT Using MRI-Based Dosimetry Anna Lettmayer Use of Adjustable Applicator System for MRI-Guided BT in Cervical Cancer Árpád Kovács 11:15 12:00 Evaluation of HDR BT Fraction Dose on Local Control and Complication in Patients with Cervical Cancer IB and IIA Małgorzata Kraszkiewicz 12:00 13:00 Lunch ORAL SESSION V Impact of Treatment Time Prolongation on Pelvic Control for Uterine Cervix Cancer Radiobiological Modelling TCP vs. Clinical Outcomes from EBM Pavol Matula NEW DEVELOPEMENTS IN BT PHYSICS INVERSE PLANNING Dimos Baltas and Tibor Major 13:00 13:20 The Role of Inverse Planning in Prostate Brachytherapy Dimos Baltas 13:20 13:35 Optimisation of Image-Based Treatment Plans for Breast HDR Implants 13:35 13:50 Inverse Planning in Gynaecological Brachytherapy Christian Kirisits 13:50 14:05 14:05 14:15 Discussion Recent and Future Developments for Brachytherapy Treatment Planning Eric Sewsingh Mehmet Üzümcu Dimos Baltas 3
4 ORAL SESSION VII PROFFERED PAPERS BRACHYTHERAPY PHYSICS Maryla Kawczyńska and Christian Kirisits Irregular vs. Regular Seed Loading Pattern in Permanent Prostate Brachytherapy Planning Georgina Fröhlich 14:15 14:45 MRI Modelling of Rectal Dosimeter Probe during MRI-Guided HDR BT for prostate: feasibility and Gergely Antal Initial experiences 14:45 15:15 Coffee Break ROUND-TABLE DISCUSSION III Development of Surface Applicator ( Results) RAISING THE PROFILE OF BRACHYTHERAPY Bogusław Maciejewski Jenő Pálvölgyi 15:15 15:30 Clinical and Economic Sunrise for Brachytherapy Bogusław Maciejewski 15:30 17:15 ORAL SESSION VIII 17:15 18:15 POSTER WALK Moderators DISCUSSION Clinical and Economic Cost-Benefit Ratio of Brachytherapy vs. Other Modalities (e.g. IMRT, Protons) Driving the Cause of Brachytherapy through better Evidence Standardisation and reproducibility (e.g. protocols) Economics (e.g. reimbursement, business plans) Technology Education Lobbying (e.g. health care authorities, health care funds, professional medical associations beyond RT, patients) Dimos Baltas Catharina Beskow Brygida Białas Gabor Kacso Christian Kirisits József Lövey Jarosław Łyczek Bogusław Maciejewski Julian Malicki Primož Petrič Pavel Slampa PROFFERED PAPERS MISCELLANEOUS BRACHYTHERAPY (OTHER THAN BREAST, GYN AND PROSTATE) Janaki Hadijev and Zoltán Takácsi-Nagy Brachytherapy Infrastructure in Poland ( ) HDR BT Endobronchial in Managing Advanced Lung Cancer Comparison of Different Protocols Palliative PDR BT in Treating Recurrent Larynx Cancer HDR BT of Skin Cancer in Material of GPCC Effectiveness of Yttrium-90 Colloid BT in Cystic Craniopharyngeomas József Lövey and Kornélia Szluha 18:15 18:45 Abstracts 1, 2, 4, 7, 8, 10,14, 15, 17, 19, 20, 25, 28, 32 18:30 19:15 Break SOCIAL EVENT AN EVENING OUT IN BUDAPEST Gala Dinner 19:15 23:00 Best Abstracts Awards Party Time Wojciech Bulski Marek Kanikowski Kolumbán Zsuzsa 4
5 Saturday, 17 October 2009 ORAL SESSION IX DEBATE ON BRACHYTHERAPY FOR LOW-RISK PROSTATE CANCER HDR VS. LDR SEEDS MONOTHERAPY Bengt Johansson and Janusz Skowronek 09:00 09:15 Seeds Brachytherapy as Treatment of Choice 09:15 09:30 HDR Brachytherapy as Treatment of Choice 09:30 09:45 Discussion 09:45 10:00 Proposal for a Central European Multicentric Randomised Clinical Trial Comparing HDR to LDR Seeds Monotherapy 10:00 10:15 VIDEO PRESENTATION II Technique and Treatment Planning of Prostate Seeds Implantation Using the Nucletron FIRST System 10:15 10:30 VIDEO PRESENTATION III Technique and Treatment Planning of HDR Prostate Using Nucletron Oncentra Prostate 10:30 11:00 New Technology for Image-Guided Adaptive Brachytherapy for Prostate Tumours Lisette van der Vight 11:00 11:20 Discussion Lisette van der Vight 11:20 11:45 Coffee break ROUND-TABLE DISCUSSION VI PRACTICE OF PROSTATE HDR AND SEEDS BRACHYTHERAPY Janusz Skowronek 11:45 12:00 Optimisation Traps of HDR to LDR Prostate Brachytherapy Greater-Poland Cancer Centre Experience Dimos Baltas 11:45 12:30 DISCUSSION Learning-curve of HDR and LDR Prostate Brachytherapy Renata Soumarová Grzegorz Zwierzchowski 5
6 ORAL SESSION X PROFFERED PAPERS PROSTATE BRACHYTHERAPY Jarosław Łyczek and Péter Ágoston Influence of Number of Needles on Prostate HDR Treatment Plan Quality Adam Chichel Salvage BT for Local Recurrences of Prostate Cancer Marzena Gawkowska- 12:30 13:15 Treated Earlier with RT Suwińska Prostate HDR BT 2 years of Treatment at Greater-Poland Cancer Center Marek Kanikowski Closure 13:15 13:30 Closing remarks Open MRI-Guided HDR BT for Prostate Cancer: Feasibility and Initial Experiences Ferenc Lakosi Jos Lamers 6
Nucletron Central Europe Users Meeting
With delight we present you the preliminary agenda for the Nucletron Central Europe Users Meeting, which will be held on 15-17 October 2009 in Budapest, Hungary. We have aimed for an inspiring programme
Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014.
Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience Richard Pötter MD BrachyNext, Miami, 2014 Disclosures Richard Pötter, MD, does not have any financial relationships or
Accreditation a tool to help reduce medical errors. Professor Arthur T Porter PC MD FACR FRCPC FACRO
Accreditation a tool to help reduce medical errors Professor Arthur T Porter PC MD FACR FRCPC FACRO Errors in Radiotherapy Radiation therapy is a highly regulated medical practice with historically low
Oncentra Brachy Comprehensive treatment planning for brachytherapy. Time to focus on what counts
Oncentra Brachy Comprehensive treatment planning for brachytherapy Time to focus on what counts Time to focus on what counts In contemporary brachytherapy, the medical physicist needs to process an increasing
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including
Radiotherapy in Hungary: present status and future needs. Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary
Radiotherapy in Hungary: present status and future needs Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary Academia Europaea Section Workshops, Bergen, 10 September,
Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.
Dictionary Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment. Applicator A device used to hold a radioactive source
Hands-on course Intensity-Modulated Radiation Therapy Treatment Planning
Hands-on course Intensity-Modulated Radiation Therapy Treatment Planning Coordinators: Dates: Venue: Iain Bruinvis, Emmy Lamers and Jelle Scheurleer 01-NOV-2009 06-NOV-2009 INHolland University of Applied
Non-coronary Brachytherapy
Non-coronary Brachytherapy I. Policy University Health Alliance (UHA) will reimburse for non-coronary brachytherapy when it is determined to be medically necessary and when it meets the medical criteria
Radiation Therapy for Prostate Cancer: Treatment options and future directions
Radiation Therapy for Prostate Cancer: Treatment options and future directions David Weksberg, M.D., Ph.D. PinnacleHealth Cancer Institute September 12, 2015 Radiation Therapy for Prostate Cancer: Treatment
Second European Blue Sky Conference
Second European Blue Sky Conference 1 Global Transformations: Consequences and Alternatives International conference in association with OECD and the UNESCO MOST Program 29-31 October, 2015, Budapest -
Radiation Therapy in Prostate Cancer Current Status and New Advances
Radiation Therapy in Prostate Cancer Current Status and New Advances Arno J. Mundt MD Professor and Chairman Dept Radiation Oncology Moores Cancer Center UCSD Radiation Therapy Wilhelm Roentgen (1845-1923)
Patient Guide. Brachytherapy: The precise answer for tackling breast cancer. Because life is for living
Patient Guide Brachytherapy: The precise answer for tackling breast cancer Because life is for living This booklet is designed to provide information that helps women who have been diagnosed with early
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) Szeged,
Radiation Therapy in Prostate Cancer Current Status and New Advances
Radiation Therapy in Prostate Cancer Current Status and New Advances Arno J. Mundt MD Professor and Chairman Dept Radiation Oncology Moores Cancer Center UCSD Presentation Welcome Overview of UCSD, Moores
Program. AUGUST 26 (Wednesday)
AUGUST 26 (Wednesday) Program 08:00 09:00 REGISTRATION Venue: Department of Transplantation and Surgery Semmelweis University Baross street 23. 1082, Budapest OPENING 09:00 09:30 Welcome Addresses and
Implementation Date: April 2015 Clinical Operations
National Imaging Associates, Inc. Clinical guideline PROSTATE CANCER Original Date: March 2011 Page 1 of 5 Radiation Oncology Last Review Date: March 2015 Guideline Number: NIA_CG_124 Last Revised Date:
Radiation Oncologists and Cancer Treatment Facilities Quick Reference Guide
Radiation Oncologists and Cancer Treatment Facilities Quick Reference Guide Effective January 1, 2015 Capital BlueCross has selected NIA Magellan 1 to provide radiation oncology benefit management services
Advances in Surgical Oncology
3-4 December 2015 Advances in Surgical Oncology 3 rd International Conference of the Medical University of Lublin 10 th anniversary of first Intraoperative Radiotherapy in Lublin 1 Scientific Chairman
Szent István Egyetem. 2100 Gödöll, Páter Károly u. 1., Tudástranszfer Központ (GPS: 47.596149, 19.361354) Szent István University
8. Magyar Nemzeti és Nemzetközi Lifelong Learning Konferencia 8 th Hungarian National and International Lifelong Learning Conference Szent István Egyetem 2100 Gödöll, Páter Károly u. 1., Tudástranszfer
Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Pre-authorization Required]
Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Pre-authorization Required] Medical Policy: MP-SU-01-11 Original Effective Date: February 24, 2011 Reviewed: February 24, 2012 Revised:
Brachytherapy in Greater Poland Cancer Centre and in Poznan the past and the presence
Review article Brachytherapy in Greater Poland Cancer Centre and in Poznan the past and the presence Janusz Skowronek, MD, PhD, Ass. Prof. Review articles Brachytherapy Department, Greater Poland Cancer
There must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required]
Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required] Medical Policy: MP-SU-01-11 Original Effective Date: February 24, 2011 Reviewed: Revised: This policy applies
NOVEL USES OF A CT-ON-RAILS IN AN INTEGRATED BRACHYTHERAPY OR SUITE
NOVEL USES OF A CT-ON-RAILS IN AN INTEGRATED BRACHYTHERAPY OR SUITE OPTMIZING YOUR BRACHYTHERAPY WORKFLOW WITH CT-ON-RAILS SYSTEM Marc Gaudet MD, MSc, MHA FRCPC Chief, Radiation Oncology Director, Oncology
MVP/Care Core National 2015 Radiation Therapy Prior Authorization List (Effective January 1, 2015)
MVP/Care Core National 2015 Radiation Therapy Prior Authorization List (Effective January 1, 2015) CODE CODE TYPE Description 0330 REVCODE RADIOLOGY/THERAPEUTIC - GENERAL CLASSIFICATION 0333 REVCODE RADIOLOGY/THERAPEUTIC
The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 2, 2015 V2
The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 2, 2015 V2 Taxonomy Data Category Number Description Data Fields and Menu Choices 1. Impact 1.1 Incident
Brachytherapy of the Uterine Corpus: Some Physical Considerations. Bruce Thomadsen. University of Wisconsin -Madison
Brachytherapy of the Uterine Corpus: Some Physical Considerations Bruce Thomadsen University of Wisconsin -Madison Conflicts of Interest The author has no known conflicts involving this presentation Learning
Dear Colleagues, We are very much looking forward to meeting you this autumn.
Dear Colleagues, Our traditional scientific meeting organized on a yearly basis - has its own charactheristics that make it a true jubilee this year as well. It was back in September 1992 that we organized
Second European Blue Sky Conference
Second European Blue Sky Conference 1 Global Transformations Consequences and Alternatives International conference in association with OECD and the UNESCO MOST Program 29-31 October, 2015, Budapest -
Cancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
Breast Cancer Accelerated Partial Breast Irradiation Bruce G. Haffty, MD Professor and Chairman Dept Radiation Oncology UMDNJ-RWJMS Cancer Institute
Breast Cancer Accelerated Partial Breast Irradiation Bruce G. Haffty, MD Professor and Chairman Dept Radiation Oncology UMDNJ-RWJMS Cancer Institute of New Jersey Rationale for Partial Breast Radiation
How To Know If You Should Get A Brachytherapy Or Radioactive Seed Implantation
MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
Basic Principles of Documentation, Billing, Coding & Compliance in Radiation Oncology
& Carl R. Bogardus, Jr., M.D. Present a 1 ½ day seminar in Nashville At Union Station Hotel June 21 & 22, 2012 Basic Principles of Documentation, Billing, Coding & Compliance in Radiation Oncology BMSi
15-17th October. conference program. CONFESSIONALITY AND UNIVERSITY IN THE MODERN WORLD 20th Anniversary of Károli University
15-17th October conference program CONFESSIONALITY AND UNIVERSITY IN THE MODERN WORLD 20th Anniversary of Károli University Welcome to the CONFESSIONALITY AND UNIVERSITY IN THE MODERN WORLD 20th Anniversary
Dear Colleagues and Friends,
Dear Colleagues and Friends, Welcome to Budapest, Hungary's largest cancer center at the National Institute of Oncology. Thank you for joining us for the IX. Breast and Face Plastic Surgery Symposia. 2012
Preliminary program 10 OCTOBER, 2014 FRIDAY. 9:10 9:30 Opening ceremony
First Announcement 10 OCTOBER, 2014 FRIDAY 8:00 9:10 Registration 9:10 9:30 Opening ceremony Scientific Session I. 9:30 10:00 Chair: Prof. György Bártfai Key-Note Lecture: Multinational trials providing
November 21 22, 2008 Siófok, Hotel Residence Hungary. Seminar on Geriatric Fractures
November 21 22, 2008 Siófok, Hotel Residence Hungary 2008 Seminar on Geriatric Fractures Course Faculty Course language: English Dear Colleagues! It is a great honor for me to invite you on behalf of the
NIA RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning
NIA RADIATION ONCOLOGY CODING STANDARD Dosimetry Planning CPT Codes: 77295, 77300, 77301, 77306, 77307, 77321, 77316, 77317, 77318, 77331, 77399 Original Date: April, 2011 Last Reviewed Date: November,
9th NATIONAL AND 4th INTERNATIONAL CONFERENCE OF LOGISTICS DIRECTORS
9th NATIONAL AND 4th INTERNATIONAL CONFERENCE OF LOGISTICS DIRECTORS 14-15th May 2015. Eger, Hotel Eger & Park****, Hungary Invitation It is our pleasure to invite you to our international conference to
GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision
RADIATION THERAPY FOR GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT GYNECOLOGIC CANCERS Gynecologic cancers
Clinical Trials and Radiation Treatment. Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto
Clinical Trials and Radiation Treatment Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto What I will cover.. A little about radiation treatment The clinical trials
Prostate Cancer Treatment
Scan for mobile link. Prostate Cancer Treatment Prostate cancer is a tumor of the prostate gland, which is located in front of the rectum and below the bladder. Your doctor may perform a physical exam,
Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate
Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_prostate
ENERGY ARBITRATION COURT ROLL OF ARBITRATORS
ENERGY ARBITRATION COURT ROLL OF ARBITRATORS PRESIDENT: MEMBERS OF THE BOARD: Dr. Faludi Zoltán Dr. Berzeviczi Attila Dr. Grmela Zoltán Dr. Lajer Zsolt Dr. Szentkereszty Ákos ARBITRATORS: 1. Dr. Balog
Horizon Blue Cross Blue Shield of New Jersey 2012 Radiation Therapy Payment Rules
55875 55876 55876 Description Transperineal placement of needles or catheters into prostate for interstitial radioelement application, with or wout cytosocopy 55920 Placement of interstitial device(s)
Re irradiation Using HDR Interstitial Brachytherapy for Locally Recurrent. Disclosure
Re irradiation Using HDR Interstitial Brachytherapy for Locally Recurrent Cervical lcancer Yasuo Yoshioka, MD Department of Radiation Oncology Osaka University Graduate School of Medicine Osaka, Japan
Prostate Cancer. What is prostate cancer?
Scan for mobile link. Prostate Cancer Prostate cancer is a tumor of the prostate gland, which is located in front of the rectum and below the bladder. Your doctor may perform a physical exam, prostate-specific
Corporate Medical Policy Brachytherapy Treatment of Breast Cancer
Corporate Medical Policy Brachytherapy Treatment of Breast Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: brachytherapy_treatment_of_breast_cancer 7/1996 5/2015 5/2016 5/2015
NEW YORK STATE DEPARTMENT OF HEALTH BUREAU OF ENVIRONMENTAL RADIATION PROTECTION EXTERNAL BEAM & BRACHYTHERAPY QUALITY ASSURANCE PROGRAM AUDIT FORM
NEW YORK STATE DEPARTMENT OF HEALTH BUREAU OF ENVIRONMENTAL RADIATION PROTECTION EXTERNAL BEAM & BRACHYTHERAPY QUALITY ASSURANCE PROGRAM AUDIT FORM Purpose: To provide licensees and registrants with a
Radiation Therapy Coverage, Coding, and Reimbursement for New Technologies
Radiation Therapy Coverage, Coding, and Reimbursement for New Technologies Presented by Susan Granucci, Healthcare Reimbursement Specialist Topics 1. Intensity Modulated Radiation Therapy (IMRT) 2. Tomotherapy
Albany Medical Center Chief Medical Physicist Radiation Oncology Imaging and Related Services
Albany Medical Center Chief Medical Physicist Radiation Oncology Imaging and Related Services POSITION SUMMARY: The Medical Physicist is responsible for assuring the high quality radiation therapy through
1. Provide clinical training in radiation oncology physics within a structured clinical environment.
Medical Physics Residency Program Overview Our Physics Residency Training is a 2 year program typically beginning July 1 each year. The first year resident will work closely with medical physicists responsible
Special Guest of the Congress. Changes in economic environment as an opportunity to improve competitiveness of listed companies
ORGANIZER 8 8 Changes in economic environment as an opportunity to improve competitiveness of listed companies Special Guest of the Congress Włodzimierz Karpiński, Minister of Treasury 17 th -18 th of
PROTON THERAPY. Proton Therapy World Market Report Edition 2015 WORLD MARKET REPORT EDITION 2015. MEDraysintell. 2015 www.medraysintell.
Proton Therapy World Market Report Edition 2015 PROTON THERAPY WORLD MARKET REPORT EDITION 2015 A report written by Paul-Emmanuel Goethals & Richard Zimmermann Page 1/7 www.medraysintell.com Proton Therapy
Localised Cancer Treatment. PCI Biotech. Amphinex a new product for localised cancer treatment
Localised Cancer Treatment PCI Biotech Amphinex a new product for localised cancer treatment Disclaimer This document (the Presentation ) has been produced by PCI Biotech Holding ASA (the Company ). The
Understanding brachytherapy
Understanding brachytherapy Brachytherapy Cancer Treatment Legacy Cancer Institute Your health care provider has requested that you receive a type of radiation treatment called brachytherapy as part of
The Science behind Proton Beam Therapy
The Science behind Proton Beam Therapy Anthony Zietman MD Shipley Professor of Radiation Oncology Massachusetts General Hospital Harvard Medical School Principles underlying Radiotherapy Radiation related
MICROPOL Hungarian Seminar and Study Visit AGENDA
MICROPOL Hungarian Seminar and Study Visit Schedule: 17-19 th of September 2013 Venue: Budapest, Hungary Thematic scope - Social impact: practices / policies capable to attract smartworkers and / or SWCs
Autoradiograph of Ra-223
Session 4 Radiation protection of patients, staff and the public during therapeutic use of sealed and unsealed radioactive sources Summary of Contributed Papers Makoto Hosono, MD PhD Kinki University School
Protons vs. CyberKnife. Protons vs. CyberKnife. Page 1 UC SF. What are. Alexander R. Gottschalk, M.D., Ph.D.
Protons vs. CyberKnife UC SF Protons vs. CyberKnife UC SF Alexander R. Gottschalk, M.D., Ph.D. Associate Professor and Director of the CyberKnife Radiosurgery Program Department of Radiation Oncology University
Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012
Radiation Oncology Nursing Care Helen Lusby Radiation Oncology Nurse BAROC 2012 Definitions Radiation Therapy: Treatment of cancer using x- ray particles that cause ionisation within the cells. External
Call for proposals to host. the. ECSITE ANNUAL CONFERENCE 2018 or ECSITE ANNUAL CONFERENCE 2019
Call for proposals to host the ECSITE ANNUAL CONFERENCE 2018 or ECSITE ANNUAL CONFERENCE 2019 Ecsite - the European network of science centres and museums - is inviting institutions to host and co-organise
Our Facility. Advanced clinical center with the newest and highly exact technology for treatment of patients with cancer pencil beam
PTC Czech The main goal of radiotherapy is to irreversibly damage tumor cells, whereas the cells of healthy tissue are damaged only reversibly or not at all. Proton therapy currently comes closest to this
With the project we hope to bring enhanced treatment for better care of our patients who will no
HKSH Symposium to Explore New Frontiers in Cancer Management Experience Sharing by Local and Overseas Experts HKSH Hopes to Introduce Proton Therapy Soon (15 June 2014, Hong Kong) A panel of renowned experts
Proton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA
Proton Therapy: Cutting Edge Treatment for Cancerous Tumors By: Cherilyn G. Murer, JD, CRA Introduction Put simply, proton therapy is a new cutting edge cancer treatment that promises better outcomes for
F I K U S Z C O N F E R E N C E
F I K U S Z C O N F E R E N C E T E C H N I C A L P R O G R A M November 3, 2006 (Friday) 9.00-10.00 Registration Hall 10.00-10.10 Opening Ceremony F19 10.10-10.40 10.40-11.10 Industry and Sciences in
Prostate Cancer Treatment: What s Best for You?
Prostate Cancer Treatment: What s Best for You? Prostate Cancer: Radiation Therapy Approaches I. Choices There is really a variety of options in prostate cancer management overall and in radiation therapy.
at a critical moment Physician Suggestion Line...
Radiation Oncology Exceptional care at a critical moment When your patients require radiation therapy, they deserve the very best care available to them. The Department of Radiation Oncology provides exceptional
New Horizons. The Future of the Eastern Partnership
New Horizons The Future of the Eastern Partnership September 15, 2011 Budapest, Hungary A d d r e s s : B é r c u. 1 3-1 5., New Horizons The Future of the Eastern Partnership If we are together nothing
National Institute of Oncology - Budapest, Hungary
- Budapest, Hungary General Information New breast cancer cases treated per year 1000 Breast multidisciplinarity team members 26 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
8 th Central European Orthopaedic Congress
8 th Central European Orthopaedic Congress June 16-17, 2010 Pécs, Hungary A N N O U N C E M E N T www.asszisztencia.hu www.ortopedtarsasag.hu 1 ANNOUNCEMENT 2 8 TH CENTRAL EUROPEAN ORTHOPAEDIC CONGRESS
Executive summary. What is proton radiotherapy?
Executive summary Health Council of the Netherlands. Proton radiotherapy. Horizon scanning report. The Hague: Health Council of the Netherlands, 2009; publication no. 2009/17 What is proton radiotherapy?
KÁROLY RÓBERT COLLEGE GYÖNGYÖS. Challenges and Prospects for Innovation between 2014-2020
KÁROLY RÓBERT COLLEGE GYÖNGYÖS Challenges and Prospects for Innovation between 2014-2020 15 th International Scientific Days 30-31 March, 2016 1 st Invitation 1 SCIENTIFIC COMMITTEE Chairperson Dinya László
ANNOUNCEMENT OF COMPETITION
: + 36 (70) 378-0544 Fax: + 36 (62) 541-670 Address: 6728 Szeged, Repülőtér Bajai út. : H-6701 Szeged, Pf.1014. Association of Hungarian Reservists Fellowship Association of Hungarian Parachutists XVII.
Szegedi Tudományegyetem
9. Magyar Nemzeti és Nemzetközi Lifelong Learning Konferencia 9 th Hungarian National and International Lifelong Learning Conference Szegedi Tudományegyetem 2013. április 18-19. Rektori Hivatal 6720 Szeged,
BIG PUBLIC INVESTMENTS IN THE CITIES OF AGGLOMERATIONS
INVITATION The Department of Urban and Spatial Planning, Faculty of Architecture, Silesian University of Technology, hereby invites participants to the second edition of the cyclical conference: REGION
Proton Therapy Center Czech
Proton Therapy Center Czech The main goal of radiotherapy is to irreversibly damage tumor cells, whereas the cells of healthy tissue are damaged only reversibly or not at all. Proton therapy currently
The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning.
The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning. KAROLINA KOKUREWICZ S U P E R V I S O R S : D I N O J A R O S Z Y N S K I, G I U S E P P E S C
IAEA Human Health Programme
Human Health Programme May Abdel-Wahab, MD, PhD Director Division of Human Health Department of Nuclear Applications International Atomic Energy Agency A UNIQUE MANDATE OF THE UN SYSTEM The Agency shall
Programme Schedule YRS 2015
SZENT ISTVÁN UNIVERSITY GÖDÖLLŐ, FACULTY OF ECONOMIC- AND SOCIAL SCIENCES SZENT ISTVÁN UNIVERSITY GÖDÖLLŐ, PHD SCHOOL OF MANAGEMENT AND BUSINESS ADMINISTRATION J. SELYE UNIVERSITY, FACULTY OF ECONOMICS
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
Dosimetry on the Intraoperative Procedure
LDR-Brachytherapy of Prostate Cancer: Impact of Post-Implant Dosimetry on the Intraoperative Procedure Dr. med. Armin Thöni Dr. phil. nat. Hans Neuenschwander PD Dr. med. Jörn Wulf Radio-Onkologie, Lindenhofspital
(JVC-12/EVC-10/AMDVG-7)
12 th Joint Vacuum Conference 10 th European Vacuum Conference 7 th Annual Meeting of the German Vacuum Society (JVC-12/EVC-10/AMDVG-7) September 22 26, 2008 Hotel Ramada****, Balatonalmádi, Lake Balaton
What is a clinical trial? An introduction for patients and families
What is a clinical trial? An introduction for patients and families Introduction Life expectancy in Europe in the first decade of this century has continued to rise. We owe this fortunate development to
